A Chinese medical device company pairing automated cytogenetics instruments with medical imaging AI for karyotyping, pathology, and screening.
Hangzhou Diagens Biotechnology
Released March 27, 2025
Multimodal medical imaging foundation model built for chromosome karyotype analysis, with 92.75% sensitivity for structural abnormality detection.